Fresenius Medical Care AG & Co. KGaA
Open
$23.01
Prev. Close
$23.02
High
$23.04
Low
$23.00
Market Snapshot
$12.86B
11.8
0.99
$20.85B
Fresenius Medical Care AG engages in the provision of products and services for individuals with renal diseases. The company is headquartered in Bad Homburg Vor Der Hohe, Hessen and currently employs 109,698 full-time employees. The firm provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD) and offers other extracorporeal therapies, as well as other healthcare services. The company has two operating segments such as care delivery segment which consolidates the global health care services business and care enablement segment includes research and development (R&D), manufacturing, supply chain, and commercial operations. The company develops and manufactures health care products, which includes dialysis and non-dialysis products. Such as hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The company owns, operates, or manages dialysis clinics sells products to other dialysis providers.
Fresenius Medical Care AG engages in the provision of products and services for individuals with renal diseases. The company is headquartered in Bad Homburg Vor Der Hohe, Hessen and currently employs 109,698 full-time employees. The firm provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD) and offers other extracorporeal therapies, as well as other healthcare services. The company has two operating segments such as care delivery segment which consolidates the global health care services business and care enablement segment includes research and development (R&D), manufacturing, supply chain, and commercial operations. The company develops and manufactures health care products, which includes dialysis and non-dialysis products. Such as hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The company owns, operates, or manages dialysis clinics sells products to other dialysis providers.
Recently from Cashu

Interwell Health Achieves Major Success in Kidney Care Model, Boosting Patient Outcomes and Savings
Fresenius Medical Care AG & Co. KGaA (Ticker: FMS) has a notable development as its subsidiary, Interwell Health, achieves outstanding results in the Kidney Care Choices (KCC) Model initiated by the U…

Fresenius Medical Care Launches Kinexus: A Game-Changer for Home Dialysis Management
Fresenius Medical Care AG & Co. KGaA (Ticker: FMS) launches kinexus, a groundbreaking digital platform aimed at revolutionizing home dialysis programs. This integrated solution is designed to support…

Fresenius Advances Renal Health Innovation at ERA Congress with AI and New Treatment Strategies
Fresenius Medical Care AG & Co. KGaA (Ticker: FMS) demonstrates its commitment to advancing renal health innovation through significant research presentations at the recent European Renal Association…

Fresenius Medical Care Reappoints Martin Fischer as CFO for Strategic Financial Leadership
Fresenius Medical Care AG & Co. KGaA (Ticker: FMS) announces the reappointment of Martin Fischer as Chief Financial Officer (CFO) for an additional five-year term, signaling the company's strategic fo…